NEW YORK--(BUSINESS WIRE)--ImClone Systems Incorporated (NASDAQ: IMCL) announced today that Thomas F. Deuel, M.D. has been appointed a director by the Company’s Board of Directors (the “Board”), effective as of July 3, 2007. “Tom Deuel has a strong scientific background in oncology and, as a former member of our scientific advisory board, is extremely knowledgeable about Erbitux® and ImClone’s extensive pipeline,” stated Alexander J. Denner, Ph.D., Chairman of ImClone Systems’ Executive Committee. “We welcome him to the Board and look forward to the important contributions he will make.”
